Montie J E
J Urol. 1979 Sep;122(3):298-9. doi: 10.1016/s0022-5347(17)56374-0.
Cancer developing after renal transplantation is a well documented event that has clinical importance and immunologic implications. The incidence and severity of these malignancies are not of the magnitude to discourage the use of transplantation as major treatment for chronic renal failure. Suppression of the immune surveillance system has been believed to be the cause of cancer after transplantation but recent data suggest that cancer after transplantation does not constitute acceptable evidence for the immune surveillance theory.
肾移植后发生癌症是一个有充分文献记载的事件,具有临床重要性和免疫学意义。这些恶性肿瘤的发病率和严重程度尚未达到足以阻碍将移植作为慢性肾衰竭主要治疗方法的程度。免疫监视系统的抑制一直被认为是移植后发生癌症的原因,但最近的数据表明,移植后癌症并不构成免疫监视理论的可接受证据。